These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23741371)

  • 1. Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations.
    Darabi Sahneh F; Scoglio C; Riviere J
    PLoS One; 2013; 8(5):e64690. PubMed ID: 23741371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct observation of a single nanoparticle-ubiquitin corona formation.
    Ding F; Radic S; Chen R; Chen P; Geitner NK; Brown JM; Ke PC
    Nanoscale; 2013 Oct; 5(19):9162-9. PubMed ID: 23921560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
    Park SJ
    Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.
    Shaw CA; Mortimer GM; Deng ZJ; Carter ES; Connell SP; Miller MR; Duffin R; Newby DE; Hadoke PW; Minchin RF
    Nanotoxicology; 2016 Sep; 10(7):981-91. PubMed ID: 27027807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Kinetics of Protein-Nanoparticle Corona Formation.
    Vilanova O; Mittag JJ; Kelly PM; Milani S; Dawson KA; Rädler JO; Franzese G
    ACS Nano; 2016 Dec; 10(12):10842-10850. PubMed ID: 28024351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.
    Cedervall T; Lynch I; Lindman S; Berggård T; Thulin E; Nilsson H; Dawson KA; Linse S
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2050-5. PubMed ID: 17267609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
    Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
    Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-protein corona complex: understanding multiple interactions between environmental factors, corona formation, and biological activity.
    Tomak A; Cesmeli S; Hanoglu BD; Winkler D; Oksel Karakus C
    Nanotoxicology; 2021 Dec; 15(10):1331-1357. PubMed ID: 35061957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of a single nanoparticle interaction with the human blood plasma proteins.
    Skakauskas V; Katauskis P
    J Biol Phys; 2018 Dec; 44(4):605-617. PubMed ID: 30209704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Modeling of Protein Corona Formation and Its Interactions with Nanoparticles and Cell Membranes for Nanomedicine Applications.
    Lee H
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33947090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
    Ahsan SM; Rao CM; Ahmad MF
    Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
    Pustulka SM; Ling K; Pish SL; Champion JA
    ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Corona Formation Impacts Nanomaterials as Drug Carriers.
    Gupta MN; Roy I
    Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analysis of Protein Corona on Precoated Protein Nanoparticles and Determined Nanoparticles with Ultralow Protein Corona and Efficient Targeting in Vivo.
    Zhong Z; Fang S; Li Y; Huang Y; Zhang Y; Chen H; Zhang J; Wang HX; Xiong H; Zou Q; Wang S
    ACS Appl Mater Interfaces; 2021 Dec; 13(48):56812-56824. PubMed ID: 34817983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.